Atrial fibrillation (AFib) is not a shockable rhythm in the way that term is typically used. In cardiac arrest protocols and automated external defibrillators (AEDs), “shockable” refers specifically to two rhythms: ventricular fibrillation (VF) and pulseless ventricular tachycardia (pVT). AFib does not fall into either category. However, AFib can be treated with a different type of electrical shock called synchronized cardioversion, which is a controlled, planned procedure rather than an emergency defibrillation.
What “Shockable” Actually Means
In emergency medicine, a shockable rhythm is one that causes cardiac arrest and can be corrected by delivering an unsynchronized electrical shock. The two shockable rhythms are ventricular fibrillation, where the heart’s lower chambers quiver chaotically and pump no blood, and pulseless ventricular tachycardia, where the lower chambers beat so fast they can’t fill with blood. Both are immediately life-threatening.
AEDs are programmed to detect these two rhythms and advise a shock only when they’re present. A shockable rhythm is generally defined as a disorganized electrical signal with an amplitude above 0.1 millivolts, or an organized rhythm faster than 180 beats per minute. Atrial-based rhythms like AFib, along with normal sinus rhythm, slow heart rates, and asystole (flatline), are all classified as non-shockable. An AED will analyze these and display a “no shock advised” message.
Why AEDs Don’t Shock AFib
AFib originates in the heart’s upper chambers (the atria), not the ventricles. While the atria fire erratically during AFib, the ventricles usually still contract and pump blood, meaning the person has a pulse. Defibrillation is designed for patients in cardiac arrest with no pulse. Shocking someone who has a pulse with an unsynchronized jolt could actually cause a more dangerous problem.
When an electrical shock lands during a specific vulnerable moment in the heartbeat cycle (the tail end of the T wave on an EKG), it can trigger ventricular fibrillation. This is called the R-on-T phenomenon, and it would turn a patient who has a pulse into one in cardiac arrest. That’s exactly why AFib isn’t treated with the same kind of shock an AED delivers.
There is one rare exception worth noting. In some cases, AFib produces such small electrical signals that an AED misreads them as fine ventricular fibrillation. One documented case involved AFib waves between 0.08 and 0.2 millivolts that confused an AED with a low detection threshold into recommending a shock. This is an error, not a correct reading, and highlights a limitation of AED algorithms rather than a reason to shock AFib.
How AFib Is Actually Shocked
AFib can be treated with electricity, just not through defibrillation. The procedure is called synchronized cardioversion. Instead of delivering a shock at a random point in the heartbeat, the machine tracks each heartbeat and times the shock to land at a safe moment, specifically on the R wave of the heart’s electrical cycle. This avoids the vulnerable window that could trigger ventricular fibrillation.
To perform this, a clinician switches the defibrillator into “synchronize” mode, which causes the monitor to mark each heartbeat with a synchronizing indicator. The shock is then delivered only when the machine confirms it’s hitting the right moment. For AFib, the American Heart Association recommends starting at 200 joules with a biphasic defibrillator.
Cardioversion for AFib is a planned, in-hospital procedure. The patient is typically sedated, and the medical team monitors the heart rhythm throughout. It’s a very different experience from the emergency scenario of bystander CPR with an AED.
Success Rates and What to Expect
Electrical cardioversion restores a normal heart rhythm immediately after the procedure in roughly two-thirds of patients. A study of 370 cardioversion attempts found a 65.7% immediate success rate, defined as the heart returning to a normal sinus rhythm right after the shock. That means about one in three patients may need additional attempts or a different treatment approach, such as medication to control the rhythm.
Even when cardioversion works initially, AFib frequently returns over time. The procedure resets the heart’s rhythm, but it doesn’t fix the underlying electrical or structural issues in the atria that caused AFib in the first place. Many patients undergo cardioversion as part of a broader treatment plan that includes medications to help maintain normal rhythm.
Preparation Before Cardioversion
One of the biggest risks of cardioversion isn’t the shock itself. It’s the possibility that blood clots have formed in the atria during AFib. When the heart snaps back into a normal rhythm, those clots can be ejected into the bloodstream and travel to the brain, causing a stroke.
To reduce this risk, patients whose AFib has lasted more than 48 hours (or an unknown duration) need at least three weeks of blood-thinning medication before the procedure. European Society of Cardiology guidelines also recommend continuing blood thinners for a minimum of four weeks after cardioversion, regardless of an individual’s stroke risk score. An alternative path involves using an imaging study called a transesophageal echocardiogram to check for clots before proceeding, which can sometimes shorten the waiting period.
When AFib Gets Shocked Immediately
There are situations where waiting three weeks isn’t an option. If AFib is causing dangerous instability, including a significant drop in blood pressure, active heart attack symptoms, acute heart failure, or a dangerously fast rate conducted through an abnormal electrical pathway, emergency cardioversion is performed right away. In these cases, the immediate threat to the patient’s life outweighs the clot risk, and the shock is delivered without the usual anticoagulation window.
This emergency scenario is still synchronized cardioversion, not defibrillation. The machine still times the shock to the safe point in the heartbeat. The only difference is that it happens urgently rather than as a scheduled procedure.